Polyrizon Ltd. (PLRZ) Financial Ratios
6 years of historical data (2020–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.90
-4% vs avg
5yr avg: 0.94
30Y Low0.7·High1.2
ROE
↑
-25.4%
↓+99% vs avg
5yr avg: -3018.6%
30Y Low-456%·High-25%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PLRZ Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Polyrizon Ltd. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $13M | $14M | $6M | — | — | — | — |
| Enterprise Value | $12M | $12M | $4M | — | — | — | — |
| P/E Ratio → | -5.70 | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — | — |
| P/B Ratio | 0.90 | 0.65 | 1.23 | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
PLRZ EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
PLRZ Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -25.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — |
| Net Profit Margin | — | — | — | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | -25.4% | -25.4% | -57.8% | -1052.6% | — | -10938.5% | -456.3% |
| ROA | -24.7% | -24.7% | -50.6% | -108.6% | -126.4% | -200.0% | -304.2% |
| ROIC | -41.8% | -41.8% | -65.4% | — | — | — | — |
| ROCE | -47.6% | -47.6% | -48.7% | -1114.0% | — | -10815.4% | -450.0% |
PLRZ Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $1M exceeds total debt of $0, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | 3.51 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.06 | -0.48 | 3.44 | — | — | -0.63 |
| Net Debt / EBITDA | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — |
| Interest Coverage | -1.99 | -1.99 | -514.00 | -317.50 | -388.50 | -354.50 | — |
Net cash position: cash ($1M) exceeds total debt ($0)
PLRZ Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Polyrizon Ltd.'s current ratio of 29.03x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 0.11x to 29.03x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 29.03 | 29.03 | 10.16 | 0.11 | 0.04 | 0.79 | 2.38 |
| Quick Ratio | 29.03 | 29.03 | 10.16 | 0.11 | 0.04 | 0.79 | 2.38 |
| Cash Ratio | 27.70 | 27.70 | 9.79 | 0.08 | 0.03 | 0.76 | 1.25 |
| Asset Turnover | — | — | — | — | — | — | — |
| Inventory Turnover | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — |
PLRZ Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Polyrizon Ltd. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $2M | $11965 | $0 | $0 | $0 | $0 |
Peer Comparison
Compare PLRZ with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PLRZYou | $13M | -5.7 | — | — | — | — | -25.4% | -41.8% | — |
 SIGA | $308M | 13.0 | 6.3 | 7.2 | 68.6% | 25.1% | 11.2% | 33.7% | 0.0 |
 AGEN | $128M | -902.9 | — | — | 29.6% | -18.0% | — | — | — |
 NVAX | $1B | 3.5 | 2.5 | — | 93.7% | 50.1% | — | — | 0.4 |
 NRXP | $65M | -2.8 | — | — | 58.8% | -1324.4% | — | — | — |
 PRPH | $426331 | -0.1 | — | — | 31.9% | -415.4% | -271.5% | -62.5% | — |
 NNOX | $105M | -1.3 | — | — | -98.2% | -466.2% | -45.6% | -35.6% | — |
 PFE | $141B | 18.2 | 10.2 | 15.5 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 MRK | $295B | 16.4 | 11.3 | 23.9 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 |
 ABBV | $415B | 99.1 | 17.0 | 23.3 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
| Healthcare Median | — | 22.0 | 14.1 | 18.7 | 63.6% | -4.8% | -32.4% | -11.2% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 6 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
PLRZ — Frequently Asked Questions
Quick answers to the most common questions about buying PLRZ stock.
What is Polyrizon Ltd.'s P/E ratio?
Polyrizon Ltd.'s current P/E ratio is -5.7x. This places it at the 50th percentile of its historical range.
What is Polyrizon Ltd.'s ROE?
Polyrizon Ltd.'s return on equity (ROE) is -25.4%. The historical average is -179.8%.
Is PLRZ stock overvalued?
Based on historical data, Polyrizon Ltd. is trading at a P/E of -5.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.